Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1

Lihua Shi, Song Li, Kelly Maurer, Zhe Zhang, Michelle Petri, Kathleen E. Sullivan

Research output: Contribution to journalArticlepeer-review


We observed increased expression of ADAMDEC1 RNA in monocytes from patients with systemic lupus erythematosus. The precise role of ADAMDEC1 is uncertain and uniquely among metalloproteinases it utilizes a zinc-coordinating aspartic acid residue which allows it to escape inhibition by tissue inhibitor of metalloprotease-3 (TIMP-3). A closely related gene encodes the protein ADAM28, which is not up-regulated in lupus. We leveraged the ability to look at both gene's promoters and enhancers simultaneously. ADAMDEC1 was up-regulated by LPS while ADAM28 was not upregulated in the short term. We identified MAP kinases and NFκB as critical cell pathways regulating the expression of ADAMDEC1. These same pathways were implicated in driving the expression of the ADAMDEC1 upstream enhancer RNAs. We demonstrated that binding of the enhancer RNAs produced from the upstream enhancer were critically important and that p300 bound to both the RNA from the enhancer and the DNA at the enhancer. P300 binding to the enhancer was dependent on NFκB. These data define the critical pathways regulating the expression of ADAMDEC1 and extend our knowledge of the roles of enhancer RNAs and mechanistically links p300 and enhancer RNAs.

Original languageEnglish (US)
Pages (from-to)312-321
Number of pages10
JournalMolecular Immunology
StatePublished - Nov 2018


  • ADAM28
  • Complement
  • Decysin
  • Epigenetic
  • Lupus
  • SLE
  • eRNA

ASJC Scopus subject areas

  • Immunology
  • Molecular Biology

Fingerprint Dive into the research topics of 'Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1'. Together they form a unique fingerprint.

Cite this